Inovio Pharmaceuticals
INO
INO
107 hedge funds and large institutions have $22.2M invested in Inovio Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.07% more ownership
Funds ownership: 37.02% → 37.09% (+0.07%)
9% less capital invested
Capital invested by funds: $24.5M → $22.2M (-$2.3M)
Holders
107
Holding in Top 10
–
Calls
$436K
Puts
$39K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$668K | |
| 3 | +$579K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$402K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$356K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$867K | |
| 3 | -$549K | |
| 4 |
Renaissance Technologies
New York
|
-$320K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$319K |
